IGFBP-3: A cell fate pivot in cancer and disease

Growth Hormone and IGF Research

Volumn 24, Issue 5, 2014, Pages 164-173

  Johnson, Michael A ^a   Firth, Sue M ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Apoptosis; Autophagy; Cancer; Cell survival; IGFBP 3

Indexed keywords

CASPASE 7; GLUCOSE REGULATED PROTEIN 78; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN; MAMMALIAN TARGET OF RAPAMYCIN; MITOGEN ACTIVATED PROTEIN KINASE; NUCLEAR RECEPTOR NUR77; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN KINASE B; RETINOIC ACID RECEPTOR ALPHA; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C RECEPTOR; SPHINGOSINE KINASE 1; SPHINGOSINE KINASE 2; VITAMIN D RECEPTOR; IGFBP3 PROTEIN, HUMAN;

APOPTOSIS; AUTOPHAGY; BIOLOGICAL ACTIVITY; CELL ADHESION; CELL FATE; CELL GROWTH; CELL MEMBRANE; CELL NUCLEUS; CELL PROTECTION; CELL SURFACE; CELL SURVIVAL; DISEASES; DNA DAMAGE; ENDOPLASMIC RETICULUM; ENZYME ACTIVATION; ENZYME INHIBITION; ENZYME REGULATION; EXTRACELLULAR MATRIX; GLIOBLASTOMA; GROWTH INHIBITION; HUMAN; MALIGNANT NEOPLASTIC DISEASE; NONHUMAN; OXIDATIVE STRESS; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN TARGETING; RETINOPATHY; REVIEW; SIGNAL TRANSDUCTION; ANIMAL; CELL DIFFERENTIATION; CELL PROLIFERATION; GENETICS; METABOLISM; NEOPLASM; PHYSIOLOGY; REGULATOR GENE;

ANIMALS; APOPTOSIS; CELL DIFFERENTIATION; CELL PROLIFERATION; DISEASE; ENDOPLASMIC RETICULUM; GENES, SWITCH; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; NEOPLASMS;

EID: 84908030928     PISSN: 10966374     EISSN: 15322238     Source Type: Journal    
DOI: 10.1016/j.ghir.2014.04.007     Document Type: Review

References (151)

1. Alami N., Page V., Yu Q., Jerome L., Paterson J., Shiry L., Leyland-Jones B. Recombinant human insulin-like growth factor-binding protein 3 inhibits tumor growth and targets the Akt pathway in lung and colon cancer models. Growth Horm. IGF Res. 2008, 18:487-496.
2. Arnoys E.J., Wang J.L. Dual localization: proteins in extracellular and intracellular compartments. Acta Histochem. 2007, 109:89-110.
3. Averbukh E., Weiss O., Halpert M., Yanko R., Moshe R., Nephesh I., Flyvbjerg A., Yanko L., Raz I. Gene expression of insulin-like growth factor-I, its receptor and binding proteins in retina under hypoxic conditions. Metabolism 1998, 47:1331-1336.
4. Bacon A.L., Harris A.L. Hypoxia-inducible factors and hypoxic cell death in tumour physiology. Ann. Med. 2004, 36:530-539.
5. Baumgartner-Parzer S.M., Wagner L., Pettermann M., Grillari J., Gessl A., Waldhausl W. High-glucose-triggered apoptosis in cultured endothelial cells. Diabetes 1995, 44:1323-1327.
6. Beilharz E.J., Russo V.C., Butler G., Baker N.L., Connor B., Sirimanne E.S., Dragunow M., Werther G.A., Gluckman P.D., Williams C.E., Scheepens A. Co-ordinated and cellular specific induction of the components of the IGF/IGFBP axis in the rat brain following hypoxic-ischemic injury. Brain Res. Mol. Brain Res. 1998, 59:119-134.
7. Bhattacharyya N., Pechhold K., Shahjee H., Zappala G., Elbi C., Raaka B., Wiench M., Hong J., Rechler M.M. Nonsecreted insulin-like growth factor binding protein-3 (IGFBP-3) can induce apoptosis in human prostate cancer cells by IGF-independent mechanisms without being concentrated in the nucleus. J. Biol. Chem. 2006, 281:24588-24601.
8. Booth B.A., Boes M., Andress D.L., Dake B.L., Kiefer M.C., Maack C., Linhardt R.J., Bar K., Caldwell E.E., Weiler J., et al. IGFBP-3 and IGFBP-5 association with endothelial cells: role of C-terminal heparin binding domain. Growth Regul. 1995, 5:1-17.
9. Boyle B.J., Zhao X.Y., Cohen P., Feldman D. Insulin-like growth factor binding protein-3 mediates 1 alpha,25-dihydroxyvitamin d(3) growth inhibition in the LNCaP prostate cancer cell line through p21/WAF1. J. Urol. 2001, 165:1319-1324.
10. Buckbinder L., Talbott R., Velasco-Miguel S., Takenaka I., Faha B., Seizinger B.R., Kley N. Induction of the growth inhibitor IGF-binding protein 3 by p53. Nature 1995, 377:646-649.
11. Bunn R.C., Fowlkes J.L. Insulin-like growth factor binding protein proteolysis. Trends Endocrinol. Metab. 2003, 14:176-181.
12. Burrows C., Holly J.M., Laurence N.J., Vernon E.G., Carter J.V., Clark M.A., McIntosh J., McCaig C., Winters Z.E., Perks C.M. Insulin-like growth factor binding protein 3 has opposing actions on malignant and nonmalignant breast epithelial cells that are each reversible and dependent upon cholesterol-stabilized integrin receptor complexes. Endocrinology 2006, 147:3484-3500.
13. Butt A.J., Fraley K.A., Firth S.M., Baxter R.C. IGF-binding protein-3-induced growth inhibition and apoptosis do not require cell surface binding and nuclear translocation in human breast cancer cells. Endocrinology 2002, 143:2693-2699.
14. Butt A.J., Martin J.L., Dickson K.A., McDougall F., Firth S.M., Baxter R.C. Insulin-like growth factor binding protein-3 expression is associated with growth stimulation of T47D human breast cancer cells: the role of altered epidermal growth factor signaling. J. Clin. Endocrinol. Metab. 2004, 89:1950-1956.
15. Chan S.S., Schedlich L.J., Twigg S.M., Baxter R.C. Inhibition of adipocyte differentiation by insulin-like growth factor-binding protein-3. Am. J. Physiol. Endocrinol. Metab. 2009, 296:E654-E663.
16. Chen J.C., Shao Z.M., Sheikh M.S., Hussain A., LeRoith D., Roberts C.T., Fontana J.A. Insulin-like growth factor-binding protein enhancement of insulin-like growth factor-I (IGF-I)-mediated DNA synthesis and IGF-I binding in a human breast carcinoma cell line. J. Cell. Physiol. 1994, 158:69-78.
17. Clemmons D.R., Camacho-Hubner C., Coronado E., Osborne C.K. Insulin-like growth factor binding protein secretion by breast carcinoma cell lines: correlation with estrogen receptor status. Endocrinology 1990, 127:2679-2686.
18. Clemmons D.R., Maile L.A. Minireview: integral membrane proteins that function coordinately with the insulin-like growth factor I receptor to regulate intracellular signaling. Endocrinology 2003, 144:1664-1670.
19. Clemmons D.R., Maile L.A., Ling Y., Yarber J., Busby W.H. Role of the integrin alphaVbeta3 in mediating increased smooth muscle cell responsiveness to IGF-I in response to hyperglycemic stress. Growth Horm. IGF Res. 2007, 17:265-270.
20. Cobb L.J., Liu B., Lee K.W., Cohen P. Phosphorylation by DNA-dependent protein kinase is critical for apoptosis induction by insulin-like growth factor binding protein-3. Cancer Res. 2006, 66:10878-10884.
21. Cobb L.J., Mehta H., Cohen P. Enhancing the apoptotic potential of insulin-like growth factor-binding protein-3 in prostate cancer by modulation of CK2 phosphorylation. Mol. Endocrinol. 2009, 23:1624-1633.
22. Colston K.W., Perks C.M., Xie S.P., Holly J.M. Growth inhibition of both MCF-7 and Hs578T human breast cancer cell lines by vitamin D analogues is associated with increased expression of insulin-like growth factor binding protein-3. J. Mol. Endocrinol. 1998, 20:157-162.
23. Conover C.A. Potentiation of insulin-like growth factor (IGF) action by IGF-binding protein-3: studies of underlying mechanism. Endocrinology 1992, 130:3191-3199.
24. Conover C.A., Bale L.K., Durham S.K., Powell D.R. Insulin-like growth factor (IGF) binding protein-3 potentiation of IGF action is mediated through the phosphatidylinositol-3-kinase pathway and is associated with alteration in protein kinase B/AKT sensitivity. Endocrinology 2000, 141:3098-3103.
25. Cook K.L., Shajahan A.N., Warri A., Jin L., Hilakivi-Clarke L.A., Clarke R. Glucose-regulated protein 78 controls cross-talk between apoptosis and autophagy to determine antiestrogen responsiveness. Cancer Res. 2012, 72:3337-3349.
26. Coverley J.A., Martin J.L., Baxter R.C. The effect of phosphorylation by casein kinase 2 on the activity of insulin-like growth factor-binding protein-3. Endocrinology 2000, 141:564-570.
27. Cuvillier O., Ader I., Bouquerel P., Brizuela L., Gstalder C., Malavaud B. Hypoxia, therapeutic resistance, and sphingosine 1-phosphate. Adv. Cancer Res. 2013, 117:117-141.
28. Daido S., Kanzawa T., Yamamoto A., Takeuchi H., Kondo Y., Kondo S. Pivotal role of the cell death factor BNIP3 in ceramide-induced autophagic cell death in malignant glioma cells. Cancer Res. 2004, 64:4286-4293.
29. De Mellow J.S., Baxter R.C. Growth hormone-dependent insulin-like growth factor (IGF) binding protein both inhibits and potentiates IGF-I-stimulated DNA synthesis in human skin fibroblasts. Biochem. Biophys. Res. Commun. 1988, 156:199-204.
30. Denko N.C., Fontana L.A., Hudson K.M., Sutphin P.D., Raychaudhuri S., Altman R., Giaccia A.J. Investigating hypoxic tumor physiology through gene expression patterns. Oncogene 2003, 22:5907-5914.
31. Dittmann K., Mayer C., Fehrenbacher B., Schaller M., Raju U., Milas L., Chen D.J., Kehlbach R., Rodemann H.P. Radiation-induced epidermal growth factor receptor nuclear import is linked to activation of DNA-dependent protein kinase. J. Biol. Chem. 2005, 280:31182-31189.
32. Dittmann K., Mayer C., Rodemann H.P. Inhibition of radiation-induced EGFR nuclear import by C225 (Cetuximab) suppresses DNA-PK activity. Radiother. Oncol. 2005, 76:157-161.
33. Fanayan S., Firth S.M., Baxter R.C. Signaling through the Smad pathway by insulin-like growth factor-binding protein-3 in breast cancer cells. Relationship to transforming growth factor-beta 1 signaling. J. Biol. Chem. 2002, 277:7255-7261.
34. Fanayan S., Firth S.M., Butt A.J., Baxter R.C. Growth inhibition by insulin-like growth factor-binding protein-3 in T47D breast cancer cells requires transforming growth factor-beta (TGF-beta) and the type II TGF-beta receptor. J. Biol. Chem. 2000, 275:39146-39151.
35. Fang P., Hwa V., Little B.M., Rosenfeld R.G. IGFBP-3 sensitizes prostate cancer cells to interferon-gamma-induced apoptosis. Growth Horm. IGF Res. 2008, 18:38-46.
36. Feldser D., Agani F., Iyer N.V., Pak B., Ferreira G., Semenza G.L. Reciprocal positive regulation of hypoxia-inducible factor 1alpha and insulin-like growth factor 2. Cancer Res. 1999, 59:3915-3918.
37. Firth S.M., Baxter R.C. Characterisation of recombinant glycosylation variants of insulin-like growth factor binding protein-3. J. Endocrinol. 1999, 160:379-387.
38. Firth S.M., Baxter R.C. Cellular actions of the insulin-like growth factor binding proteins. Endocr. Rev. 2002, 23:824-854.
39. Firth S.M., Ganeshprasad U., Baxter R.C. Structural determinants of ligand and cell surface binding of insulin-like growth factor-binding protein-3. J. Biol. Chem. 1998, 273:2631-2638.
40. Foulstone E., Prince S., Zaccheo O., Burns J.L., Harper J., Jacobs C., Church D., Hassan A.B. Insulin-like growth factor ligands, receptors, and binding proteins in cancer. J. Pathol. 2005, 205:145-153.
41. Fowler C.A., Perks C.M., Newcomb P.V., Savage P.B., Farndon J.R., Holly J.M. Insulin-like growth factor binding protein-3 (IGFBP-3) potentiates paclitaxel-induced apoptosis in human breast cancer cells. Int. J. Cancer 2000, 88:448-453.
42. Fu Y., Li J., Lee A.S. GRP78/BiP inhibits endoplasmic reticulum BIK and protects human breast cancer cells against estrogen starvation-induced apoptosis. Cancer Res. 2007, 67:3734-3740.
43. Germain P., Staels B., Dacquet C., Spedding M., Laudet V. Overview of nomenclature of nuclear receptors. Pharmacol. Rev. 2006, 58:685-704.
44. Gill Z.P., Perks C.M., Newcomb P.V., Holly J.M. Insulin-like growth factor-binding protein (IGFBP-3) predisposes breast cancer cells to programmed cell death in a non-IGF-dependent manner. J. Biol. Chem. 1997, 272:25602-25607.
45. Gluckman P.D., Guan J., Williams C., Scheepens A., Zhang R., Bennet L., Gunn A. Asphyxial brain injury-the role of the IGF system. Mol. Cell. Endocrinol. 1998, 140:95-99.
46. Granata R., Trovato L., Garbarino G., Taliano M., Ponti R., Sala G., Ghidoni R., Ghigo E. Dual effects of IGFBP-3 on endothelial cell apoptosis and survival: involvement of the sphingolipid signaling pathways. FASEB J. 2004, 18:1456-1458.
47. Granata R., Trovato L., Lupia E., Sala G., Settanni F., Camussi G., Ghidoni R., Ghigo E. Insulin-like growth factor binding protein-3 induces angiogenesis through IGF-I- and SphK1-dependent mechanisms. J. Thromb. Haemost. 2007, 5:835-845.
48. Grill C.J., Sivaprasad U., Cohick W.S. Constitutive expression of IGF-binding protein-3 by mammary epithelial cells alters signaling through Akt and p70S6 kinase. J. Mol. Endocrinol. 2002, 29:153-162.
49. Grimberg A., Coleman C.M., Burns T.F., Himelstein B.P., Koch C.J., Cohen P., El-Deiry W.S. p53-Dependent and p53-independent induction of insulin-like growth factor binding protein-3 by deoxyribonucleic acid damage and hypoxia. J. Clin. Endocrinol. Metab. 2005, 90:3568-3574.
50. Grkovic S., O'Reilly V.C., Han S., Hong M., Baxter R.C., Firth S.M. IGFBP-3 binds GRP78, stimulates autophagy and promotes the survival of breast cancer cells exposed to adverse microenvironments. Oncogene 2013, 32:2412-2420.
51. Gucev Z.S., Oh Y., Kelley K.M., Rosenfeld R.G. Insulin-like growth factor binding protein 3 mediates retinoic acid- and transforming growth factor beta2-induced growth inhibition in human breast cancer cells. Cancer Res. 1996, 56:1545-1550.
52. Hanafusa T., Yumoto Y., Nouso K., Nakatsukasa H., Onishi T., Fujikawa T., Taniyama M., Nakamura S., Uemura M., Takuma Y., Yumoto E., Higashi T., Tsuji T. Reduced expression of insulin-like growth factor binding protein-3 and its promoter hypermethylation in human hepatocellular carcinoma. Cancer Lett. 2002, 176:149-158.
53. Hashimoto Y., Niikura T., Tajima H., Yasukawa T., Sudo H., Ito Y., Kita Y., Kawasumi M., Kouyama K., Doyu M., Sobue G., Koide T., Tsuji S., Lang J., Kurokawa K., Nishimoto I. A rescue factor abolishing neuronal cell death by a wide spectrum of familial Alzheimer's disease genes and Abeta. Proc. Natl. Acad. Sci. U. S. A. 2001, 98:6336-6341.
54. Hembree J.R., Agarwal C., Beard R.L., Chandraratna R.A., Eckert R. Retinoid X receptor-specific retinoids inhibit the ability of retinoic acid receptor-specific retinoids to increase the level of insulin-like growth factor binding protein-3 in human ectocervical epithelial cells. Cancer Res. 1996, 56:1794-1799.
55. Hollier B.G., Kricker J.A., Van Lonkhuyzen D.R., Leavesley D.I., Upton Z. Substrate-bound insulin-like growth factor (IGF)-I-IGF binding protein-vitronectin-stimulated breast cell migration is enhanced by coactivation of the phosphatidylinositide 3-Kinase/AKT pathway by alphav-integrins and the IGF-I receptor. Endocrinology 2008, 149:1075-1090.
56. Hong J., Zhang G., Dong F., Rechler M.M. Insulin-like growth factor (IGF)-binding protein-3 mutants that do not bind IGF-I or IGF-II stimulate apoptosis in human prostate cancer cells. J. Biol. Chem. 2002, 277:10489-10497.
57. Huang S.S., Huang J.S. TGF-beta control of cell proliferation. J. Cell. Biochem. 2005, 96:447-462.
58. Huang S.S., Leal S.M., Chen C.L., Liu I.H., Huang J.S. Identification of insulin receptor substrate proteins as key molecules for the TbetaR-V/LRP-1-mediated growth inhibitory signaling cascade in epithelial and myeloid cells. FASEB J. 2004, 18:1719-1721.
59. Hung H., Pollak M. Regulation of IGFBP-3 expression in breast cancer cells and uterus by estradiol and antiestrogens: correlations with effects on proliferation: a review. Prog. Growth Factor Res. 1995, 6:495-501.
60. Huynh H., Yang X., Pollak M. Estradiol and antiestrogens regulate a growth inhibitory insulin-like growth factor binding protein 3 autocrine loop in human breast cancer cells. J. Biol. Chem. 1996, 271:1016-1021.
61. Ikezoe T., Tanosaki S., Krug U., Liu B., Cohen P., Taguchi H., Koeffler H.P. Insulin-like growth factor binding protein-3 antagonizes the effects of retinoids in myeloid leukemia cells. Blood 2004, 104:237-242.
62. Ikonen M., Liu B., Hashimoto Y., Ma L., Lee K.W., Niikura T., Nishimoto I., Cohen P. Interaction between the Alzheimer's survival peptide humanin and insulin-like growth factor-binding protein 3 regulates cell survival and apoptosis. Proc. Natl. Acad. Sci. U. S. A. 2003, 100:13042-13047.
63. Jarajapu Y.P., Cai J., Yan Y., Li Calzi S., Kielczewski J.L., Hu P., Shaw L.C., Firth S.M., Chan-Ling T., Boulton M.E., Baxter R.C., Grant M.B. Protection of blood retinal barrier and systemic vasculature by insulin-like growth factor binding protein-3. PLoS One 2012, 7:e39398.
64. Jogie-Brahim S., Feldman D., Oh Y. Unraveling insulin-like growth factor binding protein-3 actions in human disease. Endocr. Rev. 2009, 30:417-437.
65. Kandala P.K., Srivastava S.K. Regulation of macroautophagy in ovarian cancer cells in vitro and in vivo by controlling glucose regulatory protein 78 and AMPK. Oncotarget 2012, 3:435-449.
66. Kielczewski J.L., Jarajapu Y.P., McFarland E.L., Cai J., Afzal A., Li Calzi S., Chang K.H., Lydic T., Shaw L.C., Busik J., Hughes J., Cardounel A.J., Wilson K., Lyons T.J., Boulton M.E., Mames R.N., Chan-Ling T., Grant M.B. Insulin-like growth factor binding protein-3 mediates vascular repair by enhancing nitric oxide generation. Circ. Res. 2009, 105:897-905.
67. Koga T., Endo H., Miyamoto Y., Mukai M., Akira S., Inoue M. IGFBPs contribute to survival of pancreatic cancer cells under severely hypoxic conditions. Cancer Lett. 2008, 268:82-88.
68. Koong A.C., Denko N.C., Hudson K.M., Schindler C., Swiersz L., Koch C., Evans S., Ibrahim H., Le Q.T., Terris D.J., Giaccia A.J. Candidate genes for the hypoxic tumor phenotype. Cancer Res. 2000, 60:883-887.
69. Kricker J.A., Hyde C.E., Van Lonkhuyzen D.R., Hollier B.G., Shooter G.K., Leavesley D.I., Herington A.C., Upton Z. Mechanistic investigations into interactions between IGF-I and IGFBPs and their impact on facilitating cell migration on vitronectin. Growth Factors 2010, 28:359-369.
70. Kricker J.A., Towne C.L., Firth S.M., Herington A.C., Upton Z. Structural and functional evidence for the interaction of insulin-like growth factors (IGFs) and IGF binding proteins with vitronectin. Endocrinology 2003, 144:2807-2815.
71. Kwon Y.G., Min J.K., Kim K.M., Lee D.J., Billiar T.R., Kim Y.M. Sphingosine 1-phosphate protects human umbilical vein endothelial cells from serum-deprived apoptosis by nitric oxide production. J. Biol. Chem. 2001, 276:10627-10633.
72. Lal A., Peters H., St Croix B., Haroon Z.A., Dewhirst M.W., Strausberg R.L., Kaanders J.H., van der Kogel A.J., Riggins G.J. Transcriptional response to hypoxia in human tumors. J. Natl. Cancer Inst. 2001, 93:1337-1343.
73. Lavieu G., Scarlatti F., Sala G., Carpentier S., Levade T., Ghidoni R., Botti J., Codogno P. Regulation of autophagy by sphingosine kinase 1 and its role in cell survival during nutrient starvation. J. Biol. Chem. 2006, 281:8518-8527.
74. Leal S.M., Liu Q., Huang S.S., Huang J.S. The type V transforming growth factor beta receptor is the putative insulin-like growth factor-binding protein 3 receptor. J. Biol. Chem. 1997, 272:20572-20576.
75. Lee A.S. GRP78 induction in cancer: therapeutic and prognostic implications. Cancer Res. 2007, 67:3496-3499.
76. Lee D.Y., Yi H.K., Hwang P.H., Oh Y. Enhanced expression of insulin-like growth factor binding protein-3 sensitizes the growth inhibitory effect of anticancer drugs in gastric cancer cells. Biochem. Biophys. Res. Commun. 2002, 294:480-486.
77. Lee K.W., Cobb L.J., Paharkova-Vatchkova V., Liu B., Milbrandt J., Cohen P. Contribution of the orphan nuclear receptor Nur77 to the apoptotic action of IGFBP-3. Carcinogenesis 2007, 28:1653-1658.
78. Lee K.W., Liu B., Ma L., Li H., Bang P., Koeffler H.P., Cohen P. Cellular internalization of insulin-like growth factor binding protein-3: distinct endocytic pathways facilitate re-uptake and nuclear localization. J. Biol. Chem. 2004, 279:469-476.
79. Lee K.W., Ma L., Yan X., Liu B., Zhang X.K., Cohen P. Rapid apoptosis induction by IGFBP-3 involves an insulin-like growth factor-independent nucleomitochondrial translocation of RXRalpha/Nur77. J. Biol. Chem. 2005, 280:16942-16948.
80. Li C., Harada A., Oh Y. IGFBP-3 sensitizes antiestrogen-resistant breast cancer cells through interaction with GRP78. Cancer Lett. 2012, 325:200-206.
81. Li J., Ni M., Lee B., Barron E., Hinton D.R., Lee A.S. The unfolded protein response regulator GRP78/BiP is required for endoplasmic reticulum integrity and stress-induced autophagy in mammalian cells. Cell Death Differ. 2008, 15:1460-1471.
82. Li W., Fawcett J., Widmer H.R., Fielder P.J., Rabkin R., Keller G.A. Nuclear transport of insulin-like growth factor-I and insulin-like growth factor binding protein-3 in opossum kidney cells. Endocrinology 1997, 138:1763-1766.
83. Lin M.Z., Marzec K.A., Martin J.L., Baxter R.C. The role of insulin-like growth factor binding protein-3 in the breast cancer cell response to DNA-damaging agents. Oncogene 2014, 33(1):85-96.
84. Lin W.H., Martin J.L., Marsh D.J., Jack M.M., Baxter R.C. Involvement of insulin-like growth factor-binding protein-3 in the effects of histone deacetylase inhibitor MS-275 in hepatoma cells. J. Biol. Chem. 2011, 286:29540-29547.
85. Liu B., Lee H.Y., Weinzimer S.A., Powell D.R., Clifford J.L., Kurie J.M., Cohen P. Direct functional interactions between insulin-like growth factor-binding protein-3 and retinoid X receptor-alpha regulate transcriptional signaling and apoptosis. J. Biol. Chem. 2000, 275:33607-33613.
86. Liu B., Lee K.W., Anzo M., Zhang B., Zi X., Tao Y., Shiry L., Pollak M., Lin S., Cohen P. Insulin-like growth factor-binding protein-3 inhibition of prostate cancer growth involves suppression of angiogenesis. Oncogene 2007, 26:1811-1819.
87. Liu B., Lee K.W., Li H., Ma L., Lin G.L., Chandraratna R.A., Cohen P. Combination therapy of insulin-like growth factor binding protein-3 and retinoid X receptor ligands synergize on prostate cancer cell apoptosis in vitro and in vivo. Clin. Cancer Res. 2005, 11:4851-4856.
88. Lofqvist C., Chen J., Connor K.M., Smith A.C., Aderman C.M., Liu N., Pintar J.E., Ludwig T., Hellstrom A., Smith L.E. IGFBP3 suppresses retinopathy through suppression of oxygen-induced vessel loss and promotion of vascular regrowth. Proc. Natl. Acad. Sci. U. S. A. 2007, 104:10589-10594.
89. Lord C.J., Ashworth A. The DNA damage response and cancer therapy. Nature 2012, 481:287-294.
90. Maceyka M., Harikumar K.B., Milstien S., Spiegel S. Sphingosine-1-phosphate signaling and its role in disease. Trends Cell Biol. 2012, 22:50-60.
91. Maile L.A., Busby W.H., Sitko K., Capps B.E., Sergent T., Badley-Clarke J., Ling Y., Clemmons D.R. The heparin binding domain of vitronectin is the region that is required to enhance insulin-like growth factor-I signaling. Mol. Endocrinol. 2006, 20:881-892.
92. Mann M.J., Hendershot L.M. UPR activation alters chemosensitivity of tumor cells. Cancer Biol. Ther. 2006, 5:736-740.
93. Martin J.L., Ballesteros M., Baxter R.C. Insulin-like growth factor-I (IGF-I) and transforming growth factor-beta 1 release IGF-binding protein-3 from human fibroblasts by different mechanisms. Endocrinology 1992, 131:1703-1710.
94. Martin J.L., Baxter R.C. Transforming growth factor-beta stimulates production of insulin-like growth factor-binding protein-3 by human skin fibroblasts. Endocrinology 1991, 128:1425-1433.
95. Martin J.L., Baxter R.C. Signalling pathways of insulin-like growth factors (IGFs) and IGF binding protein-3. Growth Factors 2011, 29:235-244.
96. Martin J.L., Jambazov S. Insulin-like growth factor binding protein-3 in extracellular matrix stimulates adhesion of breast epithelial cells and activation of p44/42 mitogen-activated protein kinase. Endocrinology 2006, 147:4400-4409.
97. Martin J.L., Lin M.Z., McGowan E.M., Baxter R.C. Potentiation of growth factor signaling by insulin-like growth factor-binding protein-3 in breast epithelial cells requires sphingosine kinase activity. J. Biol. Chem. 2009, 284:25542-25552.
98. Martin J.L., Weenink S.M., Baxter R.C. Insulin-like growth factor-binding protein-3 potentiates epidermal growth factor action in MCF-10A mammary epithelial cells. Involvement of p44/42 and p38 mitogen-activated protein kinases. J. Biol. Chem. 2003, 278:2969-2976.
99. Massoner P., Colleselli D., Matscheski A., Pircher H., Geley S., Jansen Durr P., Klocker H. Novel mechanism of IGF-binding protein-3 action on prostate cancer cells: inhibition of proliferation, adhesion, and motility. Endocr. Relat. Cancer 2009, 16:795-808.
100. McCaig C., Perks C.M., Holly J.M. Intrinsic actions of IGFBP-3 and IGFBP-5 on Hs578T breast cancer epithelial cells: inhibition or accentuation of attachment and survival is dependent upon the presence of fibronectin. J. Cell Sci. 2002, 115:4293-4303.
101. McIntosh J., Dennison G., Holly J.M., Jarrett C., Frankow A., Foulstone E.J., Winters Z.E., Perks C.M. IGFBP-3 can either inhibit or enhance EGF-mediated growth of breast epithelial cells dependent upon the presence of fibronectin. J. Biol. Chem. 2010, 285:38788-38800.
102. Micutkova L., Hermann M., Offterdinger M., Hess M.W., Matscheski A., Pircher H., Muck C., Ebner H.L., Laich A., Ferrando-May E., Zwerschke W., Huber L.A., Jansen-Durr P. Analysis of the cellular uptake and nuclear delivery of insulin-like growth factor binding protein-3 in human osteosarcoma cells. Int. J. Cancer 2012, 130:1544-1557.
103. Morad S.A., Cabot M.C. Ceramide-orchestrated signalling in cancer cells. Nat. Rev. Cancer 2013, 13:51-65.
104. Natsuizaka M., Naganuma S., Kagawa S., Ohashi S., Ahmadi A., Subramanian H., Chang S., Nakagawa K.J., Ji X., Liebhaber S.A., Klein-Szanto A.J., Nakagawa H. Hypoxia induces IGFBP3 in esophageal squamous cancer cells through HIF-1alpha-mediated mRNA transcription and continuous protein synthesis. FASEB J. 2012, 26:2620-2630.
105. Oh S.H., Kim W.Y., Lee O.H., Kang J.H., Woo J.K., Kim J.H., Glisson B., Lee H.Y. Insulin-like growth factor binding protein-3 suppresses vascular endothelial growth factor expression and tumor angiogenesis in head and neck squamous cell carcinoma. Cancer Sci. 2012, 103:1259-1266.
106. Oh Y., Muller H.L., Lamson G., Rosenfeld R.G. Insulin-like growth factor (IGF)-independent action of IGF-binding protein-3 in Hs578T human breast cancer cells. Cell surface binding and growth inhibition. J. Biol. Chem. 1993, 268:14964-14971.
107. Oh Y., Muller H.L., Ng L., Rosenfeld R.G. Transforming growth factor-beta-induced cell growth inhibition in human breast cancer cells is mediated through insulin-like growth factor-binding protein-3 action. J. Biol. Chem. 1995, 270:13589-13592.
108. Oh Y., Muller H.L., Pham H., Rosenfeld R.G. Demonstration of receptors for insulin-like growth factor binding protein-3 on Hs578T human breast cancer cells. J. Biol. Chem. 1993, 268:26045-26048.
109. Orrenius S., Zhivotovsky B., Nicotera P. Regulation of cell death: the calcium-apoptosis link. Nat. Rev. Mol. Cell Biol. 2003, 4:552-565.
110. Oufattole M., Lin S.W., Liu B., Mascarenhas D., Cohen P., Rodgers B.D. Ribonucleic acid polymerase II binding subunit 3 (Rpb3), a potential nuclear target of insulin-like growth factor binding protein-3. Endocrinology 2006, 147:2138-2146.
111. Pattison S.T., Fanayan S., Martin J.L. Insulin-like growth factor binding protein-3 is secreted as a phosphoprotein by human breast cancer cells. Mol. Cell. Endocrinol. 1999, 156:131-139.
112. Peng L., Malloy P.J., Feldman D. Identification of a functional vitamin D response element in the human insulin-like growth factor binding protein-3 promoter. Mol. Endocrinol. 2004, 18:1109-1119.
113. Perks C.M., Bowen S., Gill Z.P., Newcomb P.V., Holly J.M. Differential IGF-independent effects of insulin-like growth factor binding proteins (1-6) on apoptosis of breast epithelial cells. J. Cell. Biochem. 1999, 75:652-664.
114. Perks C.M., Burrows C., Holly J.M. Intrinsic, pro-apoptotic effects of IGFBP-3 on breast cancer cells are reversible: involvement of PKA, Rho, and ceramide. Front. Endocrinol. 2011, 2:13.
115. Perks C.M., McCaig C., Clarke J.B., Clemmons D.R., Holly J.M. A non-IGF binding mutant of IGFBP-3 modulates cell function in breast epithelial cells. Biochem. Biophys. Res. Commun. 2002, 294:988-994.
116. Pyne N.J., Pyne S. Sphingosine 1-phosphate and cancer. Nat. Rev. Cancer 2010, 10:489-503.
117. Pyne N.J., Tonelli F., Lim K.G., Long J.S., Edwards J., Pyne S. Sphingosine 1-phosphate signalling in cancer. Biochem. Soc. Trans. 2012, 40:94-100.
118. Radulescu R.T. Nuclear localization signal in insulin-like growth factor-binding protein type 3. Trends Biochem. Sci. 1994, 19:278.
119. Rajah R., Valentinis B., Cohen P. Insulin-like growth factor (IGF)-binding protein-3 induces apoptosis and mediates the effects of transforming growth factor-beta1 on programmed cell death through a p53- and IGF-independent mechanism. J. Biol. Chem. 1997, 272:12181-12188.
120. Rao R.V., Peel A., Logvinova A., del Rio G., Hermel E., Yokota T., Goldsmith P.C., Ellerby L.M., Ellerby H.M., Bredesen D.E. Coupling endoplasmic reticulum stress to the cell death program: role of the ER chaperone GRP78. FEBS Lett. 2002, 514:122-128.
121. Reddy R.K., Mao C., Baumeister P., Austin R.C., Kaufman R.J., Lee A.S. Endoplasmic reticulum chaperone protein GRP78 protects cells from apoptosis induced by topoisomerase inhibitors: role of ATP binding site in suppression of caspase-7 activation. J. Biol. Chem. 2003, 278:20915-20924.
122. Ricort J.M., Lombet A., Lassarre C., Binoux M. Insulin-like growth factor binding protein-3 increases intracellular calcium concentrations in MCF-7 breast carcinoma cells. FEBS Lett. 2002, 527:293-297.
123. Rozen F., Zhang J., Pollak M. Antiproliferative action of tumor necrosis factor-alpha on MCF-7 breast cancer cells is associated with increased insulin-like growth factor binding protein-3 accumulation. Int. J. Oncol. 1998, 13:865-869.
124. Santer F.R., Bacher N., Moser B., Morandell D., Ressler S., Firth S.M., Spoden G.A., Sergi C., Baxter R.C., Jansen-Durr P., Zwerschke W. Nuclear insulin-like growth factor binding protein-3 induces apoptosis and is targeted to ubiquitin/proteasome-dependent proteolysis. Cancer Res. 2006, 66:3024-3033.
125. Scarlatti F., Bauvy C., Ventruti A., Sala G., Cluzeaud F., Vandewalle A., Ghidoni R., Codogno P. Ceramide-mediated macroautophagy involves inhibition of protein kinase B and up-regulation of beclin 1. J. Biol. Chem. 2004, 279:18384-18391.
126. Schedlich L.J., Graham L.D., O'Han M.K., Muthukaruppan A., Yan X., Firth S.M., Baxter R.C. Molecular basis of the interaction between IGFBP-3 and retinoid X receptor: role in modulation of RAR-signaling. Arch. Biochem. Biophys. 2007, 465:359-369.
127. Schedlich L.J., Le Page S.L., Firth S.M., Briggs L.J., Jans D.A., Baxter R.C. Nuclear import of insulin-like growth factor-binding protein-3 and -5 is mediated by the importin beta subunit. J. Biol. Chem. 2000, 275:23462-23470.
128. Schedlich L.J., Nilsen T., John A.P., Jans D.A., Baxter R.C. Phosphorylation of insulin-like growth factor binding protein-3 by deoxyribonucleic acid-dependent protein kinase reduces ligand binding and enhances nuclear accumulation. Endocrinology 2003, 144:1984-1993.
129. Schedlich L.J., O'Han M.K., Leong G.M., Baxter R.C. Insulin-like growth factor binding protein-3 prevents retinoid receptor heterodimerization: implications for retinoic acid-sensitivity in human breast cancer cells. Biochem. Biophys. Res. Commun. 2004, 314:83-88.
130. Seurin D., Lombet A., Babajko S., Godeau F., Ricort J.M. Insulin-like growth factor binding proteins increase intracellular calcium levels in two different cell lines. PLoS One 2013, 8:e59323.
131. Shao Z.M., Sheikh M.S., Ordonez J.V., Feng P., Kute T., Chen J.C., Aisner S., Schnaper L., LeRoith D., Roberts C.T., et al. IGFBP-3 gene expression and estrogen receptor status in human breast carcinoma. Cancer Res. 1992, 52:5100-5103.
132. Singh B., Charkowicz D., Mascarenhas D. Insulin-like growth factor-independent effects mediated by a C-terminal metal-binding domain of insulin-like growth factor binding protein-3. J. Biol. Chem. 2004, 279:477-487.
133. Spiegel S., Milstien S. Sphingosine-1-phosphate: an enigmatic signalling lipid. Nat. Rev. Mol. Cell Biol. 2003, 4:397-407.
134. Tucci M., Nygard K., Tanswell B.V., Farber H.W., Hill D.J., Han V.K. Modulation of insulin-like growth factor (IGF) and IGF binding protein biosynthesis by hypoxia in cultured vascular endothelial cells. J. Endocrinol. 1998, 157:13-24.
135. Valentinis B., Bhala A., DeAngelis T., Baserga R., Cohen P. The human insulin-like growth factor (IGF) binding protein-3 inhibits the growth of fibroblasts with a targeted disruption of the IGF-I receptor gene. Mol. Endocrinol. 1995, 9:361-367.
136. Verzola D., Villaggio B., Berruti V., Gandolfo M.T., Deferrari G., Garibotto G. Apoptosis induced by serum withdrawal in human mesangial cells. Role of IGFBP-3. Exp. Nephrol. 2001, 9:366-371.
137. Wang D., Zhao Z., Caperell-Grant A., Yang G., Mok S.C., Liu J., Bigsby R.M., Xu Y. S1P differentially regulates migration of human ovarian cancer and human ovarian surface epithelial cells. Mol. Cancer Ther. 2008, 7:1993-2002.
138. Williams A.C., Smartt H., AM H.Z., Macfarlane M., Paraskeva C., Collard T.J. Insulin-like growth factor binding protein 3 (IGFBP-3) potentiates TRAIL-induced apoptosis of human colorectal carcinoma cells through inhibition of NF-kappaB. Cell Death Differ. 2007, 14:137-145.
139. Wood W.I., Cachianes G., Henzel W.J., Winslow G.A., Spencer S.A., Hellmiss R., Martin J.L., Baxter R.C. Cloning and expression of the growth hormone-dependent insulin-like growth factor-binding protein. Mol. Endocrinol. 1988, 2:1176-1185.
140. Xi G., Hathaway M.R., White M.E., Dayton W.R. Localization of insulin-like growth factor (IGFBP)-3 in cultured porcine embryonic myogenic cells before and after TGF-beta1 treatment. Domest. Anim. Endocrinol. 2007, 33:422-429.
141. Yamada P.M., Lee K.W. Perspectives in mammalian IGFBP-3 biology: local vs. systemic action. Am. J. Physiol. Cell Physiol. 2009, 296:C954-C976.
142. Yamanaka Y., Fowlkes J.L., Wilson E.M., Rosenfeld R.G., Oh Y. Characterization of insulin-like growth factor binding protein-3 (IGFBP-3) binding to human breast cancer cells: kinetics of IGFBP-3 binding and identification of receptor binding domain on the IGFBP-3 molecule. Endocrinology 1999, 140:1319-1328.
143. Yee D., Favoni R.E., Lippman M.E., Powell D.R. Identification of insulin-like growth factor binding proteins in breast cancer cells. Breast Cancer Res. Treat. 1991, 18:3-10.
144. Yi H.K., Kim S.Y., Hwang P.H., Kim C.Y., Yang D.H., Oh Y., Lee D.Y. Impact of PTEN on the expression of insulin-like growth factors (IGFs) and IGF-binding proteins in human gastric adenocarcinoma cells. Biochem. Biophys. Res. Commun. 2005, 330:760-767.
145. Zappala G., Elbi C., Edwards J., Gorenstein J., Rechler M.M., Bhattacharyya N. Induction of apoptosis in human prostate cancer cells by insulin-like growth factor binding protein-3 does not require binding to retinoid X receptor-alpha. Endocrinology 2008, 149:1802-1812.
146. Zeitz M.J., Ay F., Heidmann J.D., Lerner P.L., Noble W.S., Steelman B.N., Hoffman A.R. Genomic interaction profiles in breast cancer reveal altered chromatin architecture. PLoS One 2013, 8:e73974.
147. Zeng L., Jarrett C., Brown K., Gillespie K.M., Holly J.M., Perks C.M. Insulin-like growth factor binding protein-3 (IGFBP-3) plays a role in the anti-tumorigenic effects of 5-aza-2'-deoxycytidine (AZA) in breast cancer cells. Exp. Cell Res. 2013, 319:2282-2295.
148. Zhang Q., Guy K., Pagadala J., Jiang Y., Walker R.J., Liu L., Soderland C., Kern T.S., Ferry R., He H., Yates C.R., Miller D.D., Steinle J.J. Compound 49b prevents diabetes-induced apoptosis through increased IGFBP-3 levels. Invest. Ophthalmol. Vis. Sci. 2012, 53:3004-3013.
149. Zhang Q., Jiang Y., Miller M.J., Peng B., Liu L., Soderland C., Tang J., Kern T.S., Pintar J., Steinle J.J. IGFBP-3 and TNF-alpha regulate retinal endothelial cell apoptosis. Invest. Ophthalmol. Vis. Sci. 2013, 54:5376-5384.
150. Zhang Q., Soderland C., Steinle J.J. Regulation of retinal endothelial cell apoptosis through activation of the IGFBP-3 receptor. Apoptosis 2013, 18:361-368.
151. Zhang Q., Steinle J.J. DNA-PK phosphorylation of IGFBP-3 is required to prevent apoptosis in retinal endothelial cells cultured in high glucose. Invest. Ophthalmol. Vis. Sci. 2013, 54:3052-3057.